About the Authors
- Hanna Brattgård
-
Roles Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Department of Translational Medicine, Lund University, Malmö, Sweden
- Per Björkman
-
Roles Conceptualization, Resources, Supervision, Writing – review & editing
Affiliations Department of Translational Medicine, Lund University, Malmö, Sweden, Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden
- Piotr Nowak
-
Roles Resources, Writing – review & editing
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Department of Medicine Huddinge, Unit of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden
- Carl Johan Treutiger
-
Roles Resources, Writing – review & editing
Affiliation Department of Infectious Diseases/Venhälsan, South General Hospital, Stockholm, Sweden
- Magnus Gisslén
-
Roles Resources, Writing – review & editing
Affiliations Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden
- Olof Elvstam
-
Roles Conceptualization, Data curation, Formal analysis, Supervision, Writing – review & editing
* E-mail: olof.elvstam@med.lu.se
Affiliations Department of Translational Medicine, Lund University, Malmö, Sweden, Department of Infectious Diseases, Växjö Central Hospital, Växjö, Sweden
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: PB has received grants from Swedish State, grants from Region Skåne, grants from Gilead Nordic Fellowship during the conduct of the study, and personal fees from Gilead, outside the submitted work. CT has received honoraria as speaker and/or advisor from GlaxoSmithKline/ViiV, outside the submitted work. MG has received research grants from Gilead Sciences and Janssen-Cilag and honoraria as speaker and/or scientific advisor from Amgen, Biogen, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Janssen-Cilag, MSD, Novocure, Novo Nordic and Sanofi, outside the submitted work. OE has received grant from Pfizer, outside the submitted work. The manuscript does not include patents, products in development or marketed products, and none of the authors report employment or consultancy as competing interest for this work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.